Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients.

NCT04164459 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: Xalost S
DRUG: Xalatan
DRUG: Taflotan-S

Sponsor

Taejoon Pharmaceutical Co., Ltd.